Estrogen Dominant Cancers: When Hormones, Genes, Toxins, Nutrition and Microbiome Converge

Estrogen plays a crucial role in the human body, especially in the development and regulation of the reproductive system. However, its influence, when unbalanced, extends beyond normal physiology and can contribute to the development of certain cancers. Among these, estrogen-driven breast cancer is one of the most studied and significant. This article examines the influence of estrogen on breast cancer and other related cancers, the function of the gut's estrobolome, estrogen dominance, BRCA gene mutations, and the effects of estrogen-mimicking toxins. It also highlights the significance of understanding your genetic tendencies concerning toxin processing, cancer susceptibilities, and nutritional strengths and weaknesses, as cellular health rarely depends on a single factor but rather on multiple elements that can lead to adverse effects.

Estrogen Dominance Cancer Umbrella. Genetic, Nutritional, Environmental, Microbiome Interplay

How Estrogen Influences Breast Cancer

Estrogen is a hormone that promotes the growth and development of breast tissue. In estrogen-driven breast cancer, cancer cells grow in response to estrogen signals. These cancers are often classified as hormone receptor-positive (ER positive), meaning they have receptors that bind to estrogen and use it to fuel their growth.

Estrogen Receptors and Cancer Growth

Breast cancer cells with estrogen receptors (ER-positive) rely on estrogen to multiply. When estrogen binds to these receptors, it activates genes that promote cell division. This process can lead to uncontrolled growth, a hallmark of cancer.

Estrogen Dominance and Its Effects

Estrogen dominance occurs when there is an imbalance between estrogen and progesterone levels, with estrogen being disproportionately high. This imbalance can increase the risk of developing estrogen-driven cancers by promoting excessive cell proliferation and reducing the body's ability to regulate cell growth.

Primary Factors of Estrogen Dominance

1. Stress: Increases cortisol levels and may inhibit progesterone

2. Body Fat: Adipose tissue is capable of producing and storing estrogen

3. Inefficient Detoxification and Elimination: Decreased liver metabolism, constipation, or gut dysbiosis can lead to estrogen recirculation

4. Environmental Chemicals: Substances like BPA, phthalates, and other xenoestrogens can imitate estrogen, particularly if genetic SNPs affect your ability to process these chemicals

1. The Liver and Its Impact on Estrogen Circulation

The liver plays a role in attaching a chemical to estrogen, allowing the body to identify it for clearance. However, if the liver is functioning sluggishly, it can slow down the clearance of estrogen.

2. The Estrobolome: Gut Microbes and Estrogen Metabolism

The estrobolome is the group of gut bacteria that can metabolize estrogen. These microorganisms affect circulating estrogen levels by breaking down estrogen metabolites, which the liver prepared for elimination, and controlling their reabsorption into the bloodstream, enabling estrogen to remain in circulation for a longer period.

Impact on Estrogen Levels

A healthy estrobolome helps maintain balanced estrogen levels by ensuring proper metabolism and excretion. Disruptions in gut bacteria, caused by antibiotics, diet, or illness, can lead to increased estrogen levels, potentially raising the risk of estrogen-driven cancers TMS.

Supporting a Healthy Estrobolome

• Eating a diet rich in fiber and fermented foods supports beneficial gut bacteria.

• Avoiding unnecessary antibiotics helps preserve the estrobolome.

• Probiotics may assist in restoring balance after disruptions.

3. Estrogen-Mimicking Toxins and Their Role in Cancer

Certain environmental chemicals, known as endocrine disruptors, mimic estrogen's effects in the body. These toxins can bind to estrogen receptors and trigger similar responses, potentially increasing cancer risk PMID: 16697129

Common Estrogen-Mimicking Toxins

• Bisphenol A (BPA), found in plastics.

• Phthalates, used in personal care products.

• Polychlorinated biphenyls (PCBs), industrial chemicals.

• Alkyphenols

  
  

Reducing Exposure

• Use BPA-free products.

• Choose natural or organic personal care items.

• Avoid exposure to industrial pollutants when possible.

Genetic Mutations in Toxin Pathways

Exposure to these toxins becomes more severe if there are genetic mutations in the pathway responsible for their processing and elimination. Genes like CYP19A1, CYP1B1, CYP1A1, COMT, MTHFR, and others are involved in handling these estrogen-mimicking toxins. If the toxins are not processed, they remain in circulation longer and bind to estrogen receptors, triggering growth hormone signaling. Understanding your susceptibility to these toxins enables more targeted interventions, either by enhancing the activity of these genes or by minimizing exposure to these chemicals.

Genes and Estrogen-Driven Cancer Risk

If the above explanation isn't already complex, cancer doesn't occur due to just one or two factors mentioned earlier. It's a continuous interaction of genetic mutations, nutritional influences, and environmental factors. In this section, we'll explore specific tendencies in cellular replication pathways. If these genes are mutated, it could result in abnormal proliferation.

A. Tumor suppressor and DNA repair genes

BRCA1, BRCA2, PALB2, TP53, PTEN, CHEK2, ATM, BRIP1, RAD51C/D, etc..

B. Estrogen specific genes

ESR1, CYP19A1, UGT1A1, COMT, HSD3B1, etc.. genes significantly increase the risk of breast and ovarian cancers. These genes normally help repair DNA damage, but when mutated, they fail to do so effectively.

Interaction with Estrogen

Research suggests that BRCA mutations may make breast tissue more sensitive to estrogen or impair the body's ability to manage estrogen-induced DNA damage. This combination can accelerate the development of estrogen-driven cancers PMID: 24638981

Risk Management for BRCA Mutation Carriers

BRCA is the most common gene mutation linked to breast cancer. It is actually a beneficial gene because it suppresses the cell cycle to identify any DNA issues and then activates repair genes to address the problem. The problem with BRCA mutations is that the gene becomes inefficient and cannot function at its full capacity, and if there are other factors involved, this can lead to the onset of cancer. Although BRCA mutations are a serious concern and are associated with high penetrance, about 70% of individuals with BRCA mutations develop breast cancer by age 70 PMID: 18513387. This raises the question of why 30% do not develop cancer. Could it be related to a complex interplay of genetic, nutritional, and environmental factors?

• Regular screenings and imaging tests.

• Hormonal therapies that block estrogen effects.

• Preventive surgeries in high-risk cases. This can also include interventions that can help upregeulate the BRCA gene allowing it to be more effcient.

Genetic and Nutritional Influences on Cancer Susceptibility

To further complicate matters, you must also consider nutritional tendencies, as nutrition significantly influences differentiation, epigenetics, and enzymatic activity. However, if you are not consuming enough of certain nutrients, or if your genes are unable to process specific nutrients due to SNPs, or if your microbiome cannot process certain nutrients, this can affect enzymatic function, differentiation, and numerous other cancer associated biochemical reactions  PMID: 32964587

Why do the factors mentioned above compound risk?

The main concern is the accumulation of risks. An individual might inherit a mutation affecting DNA repair, have reduced estrogen clearance, face ongoing exposure to xenoestrogens, and follow a diet that insufficiently supports methylation or antioxidant defense. While each factor on its own might be manageable, collectively they significantly increase the biological drive towards the development or progression of estrogen-sensitive cancers.

Other Cancers Associated with Estrogen

Estrogen's influence is not limited to breast cancer. Other cancers linked to estrogen include:

• Endometrial cancer: Estrogen stimulates the lining of the uterus, and prolonged exposure without progesterone can increase cancer risk.

• Ovarian cancer: Some ovarian cancers are hormone-sensitive and may be influenced by estrogen levels.

• Thyroid cancer: Emerging evidence suggests estrogen may play a role in thyroid cancer development.

• Prostate, lung, brain and others PMID: 35565393: PMID: 6509447; PMID: 21765856; PMID: 20658912

  
  

  Understanding estrogen's role in these cancers helps guide prevention and treatment strategies.

Next Steps

1. Testing

Testing can help with focused nutrition, herbs, medication, and more.

Examining your genes is the first step to comprehending predispositions. While not often available in clinics, this type of testing is accessible. A molecular guide can help direct these molecular tests. Some important and highly vetted tests are genetic, hormone, gut microbiome and many others. See molecular guide.

2. Assembling the intricate components

The science hasn't fully developed yet, but testing is available, along with molecular experts who can assist in linking complex data points and constructing cutting edge molecular frameworks, which can then be presented to your clinician.

3. Consult a Clinician

Consult a clinician for further clinical guidance. Molecular frameworks assist in mapping each patient's biology, enabling the clinician to swiftly decide on the next clinical steps.

Practical Steps to Manage Estrogen-Driven Cancer Risk

• Maintain a balanced diet rich in fruits, vegetables, and fiber.

• Support gut health to promote a healthy estrobolome.

• Limit exposure to estrogen-mimicking chemicals.

• Discuss hormone levels and risks with healthcare providers, especially if you have a family history of breast or ovarian cancer.

• Consider genetic testing if BRCA mutations are suspected.

PMID: 16697129 Inadera H. (2006). The immune system as a target for environmental chemicals: Xenoestrogens and other compounds. Toxicology letters, 164(3), 191–206. https://doi.org/10.1016/j.toxlet.2006.03.006

PMID: 24638981 Savage, Kienan I et al. “BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.” Cancer research vol. 74,10 (2014): 2773-2784. doi:10.1158/0008-5472.CAN-13-2611

PMID: 18513387 Evans, D Gareth et al. “Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.” BMC cancer vol. 8 155. 30 May. 2008, doi:10.1186/1471-2407-8-155

PMID: 35565393 Orzołek, Izabela et al. “Estrogens, Cancer and Immunity.” Cancers vol. 14,9 2265. 30 Apr. 2022, doi:10.3390/cancers14092265

PMID: 6509447 Nelles, Jason L et al. “Estrogen action and prostate cancer.” Expert review of endocrinology & metabolism vol. 6,3 (2011): 437-451. doi:10.1586/eem.11.20

PMID: 20658912 Chakraborty, Subhankar et al. “Lung cancer in women: role of estrogens.” Expert review of respiratory medicine vol. 4,4 (2010): 509-18. doi:10.1586/ers.10.50

 PMID: 32964587 Altea-Manzano P, Cuadros AM, Broadfield LA, Fendt SM. Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take. EMBO Rep. 2020;21(10):e50635. doi:10.15252/embr.202050635